These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 7879260

  • 21. Significance of anti-HLA and donor-specific antibodies in long-term renal graft survival.
    Saidman S.
    Transplant Proc; 2007 Apr; 39(3):744-6. PubMed ID: 17445587
    [Abstract] [Full Text] [Related]

  • 22. Primary nonfunction and preformed anti-HLA antibodies.
    Vaidya S, Orchard P, Haneke R, Fish J.
    Transplant Proc; 1995 Feb; 27(1):1033-5. PubMed ID: 7878791
    [No Abstract] [Full Text] [Related]

  • 23. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure.
    Cai J, Terasaki PI, Anderson N, Lachmann N, Schönemann C.
    Transplantation; 2009 Jul 27; 88(2):226-30. PubMed ID: 19623018
    [Abstract] [Full Text] [Related]

  • 24. Summary of the effect of de novo HLA antibodies on chronic kidney graft failure.
    Terasaki P, Lachmann N, Cai J.
    Clin Transpl; 2006 Jul 27; ():455-62. PubMed ID: 18365403
    [Abstract] [Full Text] [Related]

  • 25. The development and specificity of anti-B-cell antibodies during humoral rejection of kidney allografts.
    Hardy M, Suciu-Foca N, McKiernan T, Rohowsky C, Cianci J, Jacob J, Pierce J, Reemtsma K.
    Transplant Proc; 1979 Mar 27; 11(1):389-92. PubMed ID: 377661
    [No Abstract] [Full Text] [Related]

  • 26. Immunoadsorption with protein A in humoral acute rejection of kidney transplants: multicenter experience.
    Mastrangelo F, Pretagostini R, Berloco P, Poli L, Cinti P, Patruno P, Alfonso L, Pompei L, Carboni F, Rizzelli S.
    Transplant Proc; 1995 Feb 27; 27(1):892-5. PubMed ID: 7879221
    [No Abstract] [Full Text] [Related]

  • 27. Autoreactive IgM non-HLA antibodies are not entirely clinically irrelevant. The Manchester UK Kidney Transplant Team.
    Martin S, Dyer PA, Scott PD.
    Transplant Proc; 1992 Dec 27; 24(6):2504. PubMed ID: 1465846
    [No Abstract] [Full Text] [Related]

  • 28. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.
    Jordan SC, Tyan D, Stablein D, McIntosh M, Rose S, Vo A, Toyoda M, Davis C, Shapiro R, Adey D, Milliner D, Graff R, Steiner R, Ciancio G, Sahney S, Light J.
    J Am Soc Nephrol; 2004 Dec 27; 15(12):3256-62. PubMed ID: 15579530
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
    Lachmann N, Terasaki PI, Budde K, Liefeldt L, Kahl A, Reinke P, Pratschke J, Rudolph B, Schmidt D, Salama A, Schönemann C.
    Transplantation; 2009 May 27; 87(10):1505-13. PubMed ID: 19461487
    [Abstract] [Full Text] [Related]

  • 32. Detailed examination of HLA antibody development on renal allograft failure and function.
    Zhu L, Lee PC, Everly MJ, Terasaki PI.
    Clin Transpl; 2008 May 27; ():171-87. PubMed ID: 19711514
    [Abstract] [Full Text] [Related]

  • 33. Role of anti-idiotypic antibodies in sensitized patients awaiting renal transplantation.
    Ramounau-Pigot A, Mourad G, Cristol JP, Argiles A, Seignalet J.
    Transplant Proc; 1992 Dec 27; 24(6):2496. PubMed ID: 1465843
    [No Abstract] [Full Text] [Related]

  • 34. Monitoring of anti-HLA and anti-Major histocompatibility complex class I related chain A antibodies in living related renal donor transplantation.
    Panigrahi A, Gupta N, Siddiqui JA, Margoob A, Bhowmik D, Guleria S, Mehra NK.
    Transplant Proc; 2007 Apr 27; 39(3):759-60. PubMed ID: 17445592
    [Abstract] [Full Text] [Related]

  • 35. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.
    Li X, Ishida H, Yamaguchi Y, Tanabe K.
    Transpl Int; 2008 Dec 27; 21(12):1145-52. PubMed ID: 18803618
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
    Panigrahi A, Deka R, Bhowmik D, Dash SC, Tiwari SC, Guleria S, Mehta SN, Mehra NK.
    Clin Transplant; 2006 Dec 27; 20(1):85-90. PubMed ID: 16556160
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Immunological status in three patients, thirty years after living related renal transplantation: antibody production in long-term survivors.
    Miyamoto N, Ishida H, Furusawa M, Shimizu T, Shirakawa H, Omoto K, Tanabe K, Toma H.
    Transpl Immunol; 2008 Feb 27; 18(4):368-72. PubMed ID: 18158125
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.